Warning: include() [function.include]: URL file-access is disabled in the server configuration in /home/attornf0/public_html/att2adop/cincinnati-ohio/index.php on line 22
Warning: include(http://attorney2adoption.org/includes/ads/topblocks.php) [function.include]: failed to open stream: no suitable wrapper could be found in /home/attornf0/public_html/att2adop/cincinnati-ohio/index.php on line 22
Warning: include() [function.include]: Failed opening 'http://attorney2adoption.org/includes/ads/topblocks.php' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/attornf0/public_html/att2adop/cincinnati-ohio/index.php on line 22
Adoption Lawyers in Cincinnati Ohio
If you are searching for Cincinnati Adoption lawyer or Cincinnati law firm, then you have reached the right place. The Cincinnati Adoption Attorney directory will provide you with an attorney database that is up-to-date and simple to use. From the Adoption attorney listings you can begin your research on lawyers in Cincinnati (or other areas). To begin your search for a Lead Counsel Lawyer for Adoption case, click on our Adoption Attorney Directory to browse through hundreds of practice areas. This page features our Cincinnati Adoption Attorney Directory listings and news. We encourage all persons looking for a lawyer to view our case results and client testimonials. We handle both small and large Adoption cases.
Related Articles from Adoption Attorney
Ben Venue Laboratories to add drug-manufacturing plant in Bedford
Ben Venue Laboratories just keeps getting bigger. Following the approval of a tax abatement Monday night by Bedford City Council, the Bedford-based pharmaceutical company said it will move forward with plans to build a 144,000-square-foot manufacturing facility at its campus off Northfield Road. The project, budgeted at $71.5 million, is expected to create nearly 200 manufacturing jobs over two years, with hiring to begin soon. "It seems like we're always growing," said company spokesman Jason Kurtz. "Ben Venue's never been in a place where we haven't been hiring . . . and we do pretty well recruiting here in
College student avoids jail for pot; gets probation
A judge sentenced a Fort Lewis College student to probation for growing marijuana in San Juan National Forest. Eric Jones, 25, pleaded guilty July 28 to one count of possession with intent to distribute more than 50 marijuana plants. The charges carried a maximum prison term of 20 years, but Judge Phillip Figa sentenced him to probation, said Jeff Dorschner, spokesman for the U.S. Attorney's Office. In April, a resident called forest rangers to report seeing the same car parked at the Devil Creek trailhead near Piedra almost every day for two months. Forest Service agents checked the area
Ranbaxy to sell Terapia’s liquid business
NEW DELHI: India, the largest pharmaceutical company Ranbaxy Laboratories is the distribution of the liquid at the hearing, the manufacturing unit of its subsidiary Romanian Terapia. The company is learnt to have, discussions with several global companies to sell the equipment, worth $ 15-20 million. While Ranbaxy Laboratories has initiated discussions with all the Indian companies, the pharmaceutical industry, experts say that few national companies in the markets want audience, syrups or drugs in Romania and Europe have a view on the capital. The sale of the unit is not likely not affect the turnover of Indian society in the
Uncertainty over proposal for takeover of KSDP
ALAPPUZHA: : The failure of the State Government to make sincere moves to revive the public sector drug manufacturing company, Kerala State Drugs and Pharmaceuticals Ltd, Kalavoor here, is hindering the takeover of the company by another public sector unit, Hindustan Latex Ltd. Though the State Government, in an order dated October 5, 2002, had accorded sanction to the takeover proposal, its failure to give an assurance to Hindustan Latex on minimum purchase of the drugs produced by the company is scuttling the takeover bid. Trade unions point out that the Government's stand was against its declared policy that public
State presence in drug manufacturing sought
KURNOOL: A.G. Rajmohan, general secretary of Andhra Pradesh Medical and Sales Representatives Union, on Sunday said that revival of public sector units in drug manufacturing was the only solution to the high cost of medicines. Addressing a seminar on the prices of drugs here, he said that everybody was gearing up to exploit the future drug market in India except the Government. He said the drug market would go out of the control of Government and consumers if the Government does not have strong presence in the drug manufacturing. Consumers were already noticing the ill effects of the more leverage
Clinical Trials and the FDA
The biotechnology sector has emerged as one of the hottest of the past year. More and more investors are pouring their money into this sector, hoping that companies will translate flashy new technologies into revenue-producing drugs. While biotechnology has come of age, and the number of profitable companies with products on the market has continued to swell, the vast majority of companies are still pinning their hopes on the positive outcomes and subsequent FDA approval of the drugs being tested in clinical trials. This article is for those investors who are interested in learning a little more about the FDA
A bitter pill for Indian drug industry
Reports coming from across Asia, Africa and the Middle East indicate that a patient may be paying top market prices to buy well-known brands of neomycin eye drops and meningococcal vaccine made of tap water; paracetamol syrup made of industrial solvent; ampicillin consisting of turmeric; contraceptive pills made of wheat flour; and antimalarials, antibiotics and snake antivenom containing no active ingredients. Such fakes are to be differentiated from the cheap knock-offs of well-known global drugs that flood Asia, including India. Such knock-offs are copycat versions of the original medicine, manufactured and sold by non-patent holders, causing a loss of revenue
Merck to break ground on Durham, N.C., vaccine plant
Merck is scheduled to break ground this morning on a vaccine plant in Durham that will create about 200 jobs in drug manufacturing, a sector that state officials see as a significant economic engine. Drug-making plants in the Triangle owned by Bayer, Wyeth, GlaxoSmithKline and others already employ more than 5,000, about Source : accessmylibrary.com
Making Pills The Smart Way
Despite its high-tech image, the pharmaceutical industry is less adept at manufacturing than you might expect. One recent horror story was Schering-Plough Corp.'s (SGP ) slip-up on asthma inhalers. In 1999 and 2000, the company recalled 59 million units because it couldn't prove that the inhalers contained the active ingredient. The Food & Drug Administration, meanwhile, has found hundreds of quality violations at other companies. The woes are a symptom of a deeper problem: factory processes so antiquated that companies typically can't even pinpoint the causes of snafus. "Manufacturing has been the poor stepchild of the pharmaceutical industry," says Jeffrey
Speakers stressed on good drug manufacturing practices.
PESHAWAR September 26: Speakers at a workshop Sunday urged drug manufacturing firms to adopt good manufacturing practices for the production of high quality medicines and promotion of traditional drugs. Dr Farzana Malik, Chief National Coordinator, Drug Control and Traditional Medicines Division said resources were fast shrinking indicating a reversion to traditional medicines which needed to start preparation from now. "By doing this, we can save major portion of our foreign exchange consumed by the import of costly materials for manufacturing of non-traditional medicines," she said. The workshop entitled "Adoption of Good Manufacturing Practices and Quality Assurances", jointly organised by the